Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device

Acclarent breathes in $26m for sinus treatment

This article was originally published in Clinica

  • News

Executive Summary

Menlo Park, California-based Acclarent is to ramp up commercialisation of its balloon catheter-based sinus treatment, Balloon Sinuplasty, after receiving $26m in new capital. The funds came from Acclarent's existing shareholders as well as new investor Johnson & Johnson. Part of the proceeds will also go towards advancing development of Acclarent's pipeline products and clinical studies.

Table

View full table

Topics

Tags:
Medical Device
Latest Headlines

Global Medtech Guidance Tracker: April 2024

Front Line Medical Technologies Announce CE Mark For COBRA-OS

Recalls Round-Up: Class 1s For BioMérieux, Fresenius, Draeger, More

New Guidance For Breast Cancer Screening Drops Age Of First Scan To 40

See All
UsernamePublicRestriction

Register

MT042600

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By